Campbell & CO Investment Adviser LLC raised its position in shares of CorVel Corp. (NASDAQ:CRVL – Free Report) by 182.3% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 9,864 shares of the business services provider’s stock after buying an additional 6,370 shares during the quarter. Campbell & CO Investment Adviser LLC’s holdings in CorVel were worth $1,014,000 at the end of the most recent quarter.
Several other institutional investors have also made changes to their positions in CRVL. Xponance Inc. lifted its position in shares of CorVel by 4.9% in the 1st quarter. Xponance Inc. now owns 2,008 shares of the business services provider’s stock valued at $225,000 after acquiring an additional 94 shares in the last quarter. Ballentine Partners LLC lifted its holdings in shares of CorVel by 4.2% in the first quarter. Ballentine Partners LLC now owns 2,531 shares of the business services provider’s stock valued at $283,000 after purchasing an additional 102 shares in the last quarter. Atria Investments Inc boosted its position in shares of CorVel by 1.3% in the second quarter. Atria Investments Inc now owns 14,646 shares of the business services provider’s stock worth $1,505,000 after buying an additional 186 shares during the period. Vanguard Personalized Indexing Management LLC grew its holdings in shares of CorVel by 4.1% during the second quarter. Vanguard Personalized Indexing Management LLC now owns 5,534 shares of the business services provider’s stock valued at $569,000 after buying an additional 217 shares in the last quarter. Finally, Meeder Asset Management Inc. acquired a new position in CorVel during the first quarter valued at $25,000. 51.36% of the stock is owned by hedge funds and other institutional investors.
CorVel Price Performance
Shares of CorVel stock opened at $77.23 on Thursday. The firm has a market cap of $3.96 billion, a price-to-earnings ratio of 39.81 and a beta of 0.98. The stock has a 50-day simple moving average of $77.34 and a 200-day simple moving average of $92.38. CorVel Corp. has a 52-week low of $70.47 and a 52-week high of $128.61.
Insider Transactions at CorVel
In other news, CFO Brandon O’brien sold 1,764 shares of the firm’s stock in a transaction on Monday, September 8th. The shares were sold at an average price of $91.54, for a total transaction of $161,476.56. Following the transaction, the chief financial officer owned 8,948 shares in the company, valued at approximately $819,099.92. This trade represents a 16.47% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Maxim Shishin sold 12,000 shares of the company’s stock in a transaction on Wednesday, August 20th. The stock was sold at an average price of $89.16, for a total transaction of $1,069,920.00. Following the completion of the sale, the insider owned 7,050 shares of the company’s stock, valued at $628,578. This represents a 62.99% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 21,050 shares of company stock worth $1,791,841 in the last 90 days. 44.56% of the stock is owned by insiders.
Wall Street Analyst Weigh In
Several research firms have weighed in on CRVL. Weiss Ratings reaffirmed a “hold (c)” rating on shares of CorVel in a research note on Tuesday, October 14th. Wall Street Zen cut shares of CorVel from a “buy” rating to a “hold” rating in a report on Saturday, November 8th. One research analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, CorVel presently has a consensus rating of “Hold”.
View Our Latest Stock Report on CRVL
CorVel Company Profile
CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.
Featured Stories
- Five stocks we like better than CorVel
- 3 Dividend Kings To Consider
- Rare Earth Stocks: The Truce That Isn’t a Truce
- With Risk Tolerance, One Size Does Not Fit All
- Carving Up Profits: 3 Food Stocks on the Thanksgiving Table
- Do ETFs Pay Dividends? What You Need to Know
- C3.ai’s Reset: Why New Leadership Could Spark a Turnaround
Receive News & Ratings for CorVel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CorVel and related companies with MarketBeat.com's FREE daily email newsletter.
